The global demand for Pseudouridine Market is presumed to reach the market size of nearly USD 994.52 MN by 2028 from USD 90.21 MN in 2021 with a CAGR of 40.9% under the study period 2022 - 2028.
Pseudouridine is a tumour marker used to guide the diagnosis, monitoring, and efficacy assessment of malignancies, including lung, breast, and liver tumours. Pseudouridine was first discovered in the human body as a component of tRNA (transfer RNA), a form of RNA. In cellular RNA, the most common RNA alteration is pseudouridine. After transcription and subsequent synthesis, RNA can be modified with approximately 100 chemically different changes. In addition to the four conventional nucleotides, these can potentially affect RNA expression post-transcriptionally and play a range of roles in the cell, including translation, localization, and RNA stability. Pseudouridine is a C5-glycoside isomer of uridine with a C-C link between C1 of the ribose sugar and C5 of uracil rather than the usual C1-N1 bond seen in uridine. Because of the C-C link, it has additional rotational mobility and conformational flexibility. Furthermore, the N1 position of pseudouridine contains another hydrogen bond donor.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pseudouridine. The growth and trends of pseudouridine industry provide a holistic approach to this study.
Market Segmentation
This section of the pseudouridine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Application
- Mrna Technology
- Molecular Biology
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Pseudouridine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Pseudouridine Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pseudouridine market include YAMASA CORPORATION, Biosynth Carbosynth, TCI America, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
